| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,454.00
|
|
Change (%)
|
47.15 (1.96%)
|
|
Best Buy (RS)
|
2450.55(x15)
|
|
Best Sell (RS)
|
2460(x7)
|
|
Today's Range (RS)
|
2,434.85
-
2,460.65
|
|
52-Week Range (RS)
|
2,218.00
-
3,515.95
|
|
Beta (1 Year)
|
0.62
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| GlaxoSmithKline Pharmaceuticals to hold AGM |
| Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend |
| GlaxoSmithKline Pharmaceuticals to announce Quarterly Result |
| Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology |
| Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter |
| GlaxoSmithKline Pharmaceuticals to table results |
|
|
|
| Incoporation Year : 1924 |
| Chairman : Renu S Karnad |
| Ownership Group : MNC Asc-Glaxo |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030 |
Phone:91-022-24959595
Fax:91-022-24959494 |
| E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com |
| URL : http://www.gsk-india.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
06-May-2026 |
2424.30 |
-0.72 |
| 1Month |
13-Apr-2026 |
2409.85 |
-0.12 |
| 3Month |
13-Feb-2026 |
2593.90 |
-7.21 |
| 6Month |
13-Nov-2025 |
2493.55 |
-3.48 |
| 1Year |
13-May-2025 |
2790.15 |
-13.74 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Midcap Fund |
1.21 |
280.37 |
| Kotak Large & Midcap Fund |
0.85 |
257.00 |
| Nippon India Pharma Fund |
2.55 |
213.37 |
| Nippon India Growth Mid Cap Fund |
0.29 |
130.60 |
| SBI Dividend Yield Fund |
1.25 |
105.14 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
27,504.10 |
0.89 |
35,921.55 |
25,164.00 |
57,930.16 |
| Pfizer Ltd |
4,635.70 |
0.64 |
5,987.65 |
4,250.85 |
21,073.24 |
| Astrazeneca Pharma India Ltd |
8,372.20 |
0.00 |
10,653.05 |
7,630.00 |
20,930.50 |
| Sanofi Consumer Healthcare India Ltd |
4,630.00 |
0.64 |
5,954.00 |
3,950.50 |
10,595.12 |
| Procter & Gamble Health Ltd |
5,268.75 |
0.89 |
6,700.00 |
4,699.70 |
8,668.53 |
|
|
|
|